Companies Disrupting the Healthcare Industry: $IPA
Post# of 49
https://topnewsguide.com/2022/08/19/companies...blfe-rshn/
IPA/Immunoprecise Antibodies Ltd. – (NASDAQ: IPA) (TSXV: IPA) – The stock has been witnessing a consistent uptrend over the past month with a gain of over 55%. Impressively, the stock is now trading well above its 50-Day and 200-Day moving averages of $4.30 and $5.10 respectively.
In the FY 2022, the Company achieved record revenues of $19.4 million, up 8.1% from $17.9 million in the fiscal year 2021 The Company achieved record revenues of $5.2 million for the three months ended April 30, 2022, an increase of 7.4% over the same period last year. The Company achieved an increase in CRO revenue (total revenue minus Talem asset out-licensing revenue) of 15.9% over the same period last year.